|Event Time:||Sunday April 23, 2017 1:00 pm to 3:00 pm|
|Description:||A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.|
|2:35 PM - 3:00 PM||Discussion||Na Tosha N. Gatson MD, PhD|
|Na Tosha N. Gatson, MD, PhD||Dr. Gatson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure (Optune).|
|1:00 PM||001||Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study||
Dr. Liedtke has received personal compensation for activities with Prothena, Amgen, Takeda, and Pfizer as a consultant or advisor. Dr. Liedtke has received research support from Prothena, Amgen, Takeda, Pfizer, Celgene, and Novartis.
|1:12 PM||002||Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion||
Dr. Naeije has nothing to disclose.
|1:24 PM||003||Long-Term Risk of Seizures in Survivors of Sepsis||
Michael Reznik, MD
Dr. Reznik has nothing to disclose.
|1:36 PM||004||Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices||
Dr. Ya'qoub has nothing to disclose.
|1:48 PM||005||Resting cerebral perfusion impairment in Type 2 Diabetes||
Dr. Dai has nothing to disclose.
|2:00 PM||006||Clinical features of post-vaccination Guillain-Barrè Syndrome (GBS) in the Republic of Korea||
Bum Chun Suh
Dr. Suh has nothing to disclose.
|2:12 PM||007||Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX)||
Sabrina Kuespert, PhD
Dr. Kuespert has nothing to disclose.
|2:24 PM||008||Glia maturation factor inhibits mitochondrial biogenesis, increase oxidative stress and apoptotic cell death in dopaminergic neurons||
Govindhasamy Pushpavathi Selvakumar
Dr. Selvakumar has nothing to disclose.
Ready to register for the 2018 AAN Annual Meeting?
|7:00 AM-7:45 AM|
|Yoga (All-Levels Vinyasa)||Jamie Heath MD|
|7:00 AM-9:00 AM|
|C216||Neuroendocrine Update: Nuts and Bolts of What You Need to Know||Alison Pack MD|
|C220||Drugs and Toxin-induced Neurologic Emergencies||Sara Hocker MD|
|11:30 AM-5:30 PM|
|P6||Poster Session VI|
|12:00 PM-12:30 PM|
|How to Bridge to Careers in Industry||Jose Cavazos MD, PhD, FAAN|
|12:00 PM-12:45 PM|
|Outsmart Stress||Marie Pasinski MD|
|12:00 PM-1:00 PM|
|The Neurology of Creativity at the Keyboard||Phillip Pearl MD, FAAN|
|1:00 PM-3:00 PM|
|C228||Neuroimaging for the General Neurologist I: Brain||Jennifer McVige MD|
|C230||Neurologic Complications of Medical and Surgical Therapies||Sara Hocker MD|
|C233||Actualización Científica Durante el Congreso Anual II||Jose Cavazos MD, PhD, FAAN|
|S50||Updates in General Neurology|
|3:30 PM-5:30 PM|
|C237||Neurologic Complications of Medical Disease||Sara Hocker MD|
|C240||Neuroimaging for the General Neurologist II: Brain||Jennifer McVige MD|